Invest in

Fighting Fat

17.9%
2.4%
0.3%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
17.9%
2.4%
0.3%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
48.6% Diabetes Care 0.5%
15.3% Merck & Company Inc. (new) MRK 13.9%
14.9% Sanofi SNY 8.0%
11.8% Novo Nordisk A/S NVO 33.0%
2.5% Astrazeneca Plc ADR AZN 5.5%
2.1% Alkermes plc ALKS 32.8%
1.9% Integer Holdings Corporation ITGR --
46.1% Weight Management 98.8%
24.3% NutriSystem Inc NTRI 158.2%
8.9% MEDIFAST INC MED 52.7%
5.9% Weight Watchers International Inc WTW 28.5%
3.4% Nu Skin Enterprises Inc. (A) NUS 50.5%
1.7% USANA Health Sciences Inc. USNA 10.1%
1.2% Vitamin Shoppe Inc VSI 36.0%
0.6% GNC Holdings Inc. Class A GNC 76.7%
5.3% Weight Loss Drugs 24.4%
5.3% Arena Pharmaceuticals Inc. ARNA 24.4%

Quotes delayed 15 mins. Currently Apr 26, 2017 11:34:35 AM. Fields are marked with -- when data is unavailable.